Stephanie Lheureux

25PUBLICATIONS
248CO-AUTHORS
Molecular targetsPredictive and prognostic markersCancer therapy (excl. chemotherapy and radiation therapy)PharmacogenomicsCancer cell biology
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (25)

|Jun 01, 2026
Antibody-drug conjugates in gynecologic cancers.

|Mar 26, 2026
Preclinical Combination Targeting VEGF and PI3K in a Rare, Aggressive Mixed Endometrial Carcinoma: An Applied Case Report.

Nikolina Radulovich, Pamela Soberanis Pina, Molly L Udaskin

|Jan 21, 2026
Camonsertib, an ATRi, in Combination with Low-Dose Gemcitabine in Solid Tumors with DNA Damage Response Aberrations: Preclinical and Phase Ib Results.

Ezra Y Rosen, Timothy A Yap, Elisa Fontana

|Jul 24, 2025
Genomic and Epigenomic ctDNA Profiling in Liquid Biopsies from Heavily Pretreated Patients with DNA Damage Response-Deficient Tumors.

Ian M Silverman, Joseph D Schonhoft, Benjamin Herzberg

|Jun 04, 2025
Novel Systemic Anticancer Treatments and Health Services Use at the End of Life Among Adults With Cancer.

Javaid Iqbal, Rahim Moineddin, Kieran L Quinn

|Apr 22, 2025
ADAGIO: A Phase IIb, Open-Label, Single-Arm, Multicenter Study Assessing the Efficacy and Safety of Adavosertib (AZD1775) as Treatment for Recurrent or Persistent Uterine Serous Carcinoma.

Joyce F Liu, Nicoletta Colombo, Amit M Oza

Pageof 5

Frequent Collaborators

6 joint publications

Amit Oza

3 joint publications

Danielle Ulanet

3 joint publications

Trevor J Pugh

3 joint publications

Benedito A Carneiro